Document 0064
 DOCN  M9460064
 TI    Nasal T-cell lymphoma: a case presentation.
 DT    9408
 AU    Liepert DR; Kudryk WH; Jewell LD; Department of Surgery, University of
       Alberta Hospital, Edmonton,; Canada.
 SO    J Otolaryngol. 1994 Feb;23(1):32-5. Unique Identifier : AIDSLINE
       MED/94223754
 AB    Nasal lymphoma represents 2.2 to 6.8% of extranodal lymphomas and
       presents a difficult diagnosis due to the variability of cell
       populations. Lesions may evolve de novo or may develop as a spectrum of
       midline lethal granuloma (MLG). The majority of extranodal disease is
       felt to be of B-cell origin, but there is evidence that those associated
       with MLG are of T-cell origin. We present a case of a 41-year-old
       Jamaican female with recurrent lesions of the nasal tip and vestibule
       beginning at age 16. Intensive investigation and review of the pathology
       continued to show nonspecific granuloma. However, at age 34, the lesion
       was diagnosed as T-cell lymphoma (HTLV-I related), and a later review of
       the slides suggests this may have been present as early as 8 years
       before diagnosis. She received 4000 cGy to the nose and nasopharynx over
       25 treatments. Although the question of two small axillary nodes exists,
       the primary site has been disease free for 7 years.
 DE    Adult  Case Report  Female  Human  Leukemia-Lymphoma, T-Cell, Acute,
       HTLV-I-Associated/*PATHOLOGY  Lymphoma, T-Cell, Cutaneous/*PATHOLOGY
       Nose Neoplasms/*PATHOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).